Martijn J.W. Evers

1.4k total citations
10 papers, 932 citations indexed

About

Martijn J.W. Evers is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Martijn J.W. Evers has authored 10 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Martijn J.W. Evers's work include RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (4 papers) and MicroRNA in disease regulation (4 papers). Martijn J.W. Evers is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (4 papers) and MicroRNA in disease regulation (4 papers). Martijn J.W. Evers collaborates with scholars based in Netherlands, Austria and Germany. Martijn J.W. Evers's co-authors include Raymond M. Schiffelers, Pieter Vader, Olivier G. de Jong, Joost P. G. Sluijter, Sander A. A. Kooijmans, Jayesh A. Kulkarni, Pieter R. Cullis, Roy van der Meel, Linglei Jiang and Enrico Mastrobattista and has published in prestigious journals such as Nano Letters, Accounts of Chemical Research and Journal of Controlled Release.

In The Last Decade

Martijn J.W. Evers

10 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martijn J.W. Evers Netherlands 9 789 247 178 97 76 10 932
Elias Quijano United States 17 1.0k 1.3× 153 0.6× 145 0.8× 199 2.1× 67 0.9× 28 1.4k
Ryan L. Setten United States 8 1.1k 1.4× 284 1.1× 110 0.6× 68 0.7× 106 1.4× 10 1.3k
Juliana M. Layzer United States 12 1.2k 1.5× 156 0.6× 162 0.9× 83 0.9× 130 1.7× 20 1.4k
Timothy Racie United States 3 844 1.1× 164 0.7× 86 0.5× 110 1.1× 105 1.4× 5 987
Masaharu Somiya Japan 16 571 0.7× 209 0.8× 138 0.8× 83 0.9× 195 2.6× 34 846
Jilian R. Melamed United States 14 638 0.8× 83 0.3× 175 1.0× 155 1.6× 121 1.6× 22 884
Liu Liang Qin China 5 772 1.0× 154 0.6× 85 0.5× 106 1.1× 102 1.3× 6 893
Tongren Yang China 13 835 1.1× 108 0.4× 198 1.1× 90 0.9× 188 2.5× 18 1.1k
Luke H. Rhym United States 11 719 0.9× 111 0.4× 72 0.4× 66 0.7× 65 0.9× 12 802
Marco Maugeri Sweden 13 1.2k 1.5× 532 2.2× 85 0.5× 60 0.6× 275 3.6× 15 1.4k

Countries citing papers authored by Martijn J.W. Evers

Since Specialization
Citations

This map shows the geographic impact of Martijn J.W. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn J.W. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn J.W. Evers more than expected).

Fields of papers citing papers by Martijn J.W. Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn J.W. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn J.W. Evers. The network helps show where Martijn J.W. Evers may publish in the future.

Co-authorship network of co-authors of Martijn J.W. Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn J.W. Evers. A scholar is included among the top collaborators of Martijn J.W. Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn J.W. Evers. Martijn J.W. Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Evers, Martijn J.W., et al.. (2025). T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles. Journal for ImmunoTherapy of Cancer. 13(7). e011759–e011759. 8 indexed citations
2.
Evers, Martijn J.W., Wenjuan Du, Qiangbing Yang, et al.. (2022). Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. Journal of Controlled Release. 343. 207–216. 70 indexed citations
3.
Evers, Martijn J.W., Simonides Immanuel van de Wakker, Olivier G. de Jong, et al.. (2021). Functional siRNA Delivery by Extracellular Vesicle–Liposome Hybrid Nanoparticles. Advanced Healthcare Materials. 11(5). e2101202–e2101202. 154 indexed citations
4.
Jong, Olivier G. de, et al.. (2021). Natural or Synthetic RNA Delivery: A Stoichiometric Comparison of Extracellular Vesicles and Synthetic Nanoparticles. Nano Letters. 21(4). 1888–1895. 130 indexed citations
5.
Evers, Martijn J.W., et al.. (2020). Feasibility Study for Bedside Production of Recombinant Human Acid α-Glucosidase: Technical and Financial Considerations. Current Pharmaceutical Biotechnology. 21(6). 467–479. 1 indexed citations
6.
Jong, Olivier G. de, Sander A. A. Kooijmans, Linglei Jiang, et al.. (2019). Drug Delivery with Extracellular Vesicles: From Imagination to Innovation. Accounts of Chemical Research. 52(7). 1761–1770. 270 indexed citations
7.
Evers, Martijn J.W., Jayesh A. Kulkarni, Roy van der Meel, et al.. (2018). State‐of‐the‐Art Design and Rapid‐Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery. Small Methods. 2(9). 223 indexed citations
8.
Blenke, Erik Oude, Martijn J.W. Evers, Volker Baumann, et al.. (2017). Critical evaluation of quantification methods for oligonucleotides formulated in lipid nanoparticles. International Journal of Pharmaceutics. 548(2). 793–802. 11 indexed citations
9.
Blenke, Erik Oude, et al.. (2016). Strategies for the Activation and Release of the Membranolytic Peptide Melittin from Liposomes Using Endosomal pH as a Trigger. Bioconjugate Chemistry. 28(2). 574–582. 19 indexed citations
10.
Blenke, Erik Oude, Martijn J.W. Evers, Enrico Mastrobattista, & John van der Oost. (2016). CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential. Journal of Controlled Release. 244. 139–148. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elias Quijano Breakdown of academic impact, for papers by Ryan L. Setten Breakdown of academic impact, for papers by Juliana M. Layzer Breakdown of academic impact, for papers by Timothy Racie Breakdown of academic impact, for papers by Masaharu Somiya Breakdown of academic impact, for papers by Jilian R. Melamed Breakdown of academic impact, for papers by Liu Liang Qin Breakdown of academic impact, for papers by Tongren Yang Breakdown of academic impact, for papers by Luke H. Rhym Breakdown of academic impact, for papers by Marco Maugeri
Rankless by CCL
2026